Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.05
+0.15 (0.84%)
Apr 24, 2025, 12:53 PM CST
-58.88%
Market Cap 1.01B
Revenue (ttm) 895.32M
Net Income (ttm) -57.21M
Shares Out 55.81M
EPS (ttm) -1.03
PE Ratio n/a
Forward PE n/a
Dividend 0.40 (2.23%)
Ex-Dividend Date n/a
Volume 12,002
Average Volume 70,162
Open 18.00
Previous Close 17.90
Day's Range 17.50 - 18.05
52-Week Range 16.00 - 47.35
Beta 0.10
RSI 35.21
Earnings Date Apr 25, 2025

About Anxo Pharmaceutical

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroentero... [Read more]

Sector Healthcare
Founded 2003
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6677
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.